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Background: While primary hyperhidrosis can be seen in men, accompanying hot flushes is rarely seen in men.
Primary hyperhidrosis is thought to be related to overactivity of the sympathetic nervous system while hot flushes
are believed to be related to altered peripheral vascular reactivity and a narrowed thermoregulatory zone.
Case presentation: I report the case of a 29-year-old man of Arab origin who presented to a dermatology clinic
with a complaint of generalized sweating, with heavier involvement of his inguinal region, axilla, and lower back.
His complaint was associated with a transient hot sensation and erythema over the affected areas. He did not
respond to topical antiperspirants containing aluminum chloride, topical aluminum chloride, or to botulinum toxin
A injected in both inguinal areas. He was then referred to an endocrinology clinic to rule out secondary causes of
hyperhidrosis and hot flushes; a primary diagnosis was confirmed. He did not respond to oral glycopyrrolate and
additionally was complaining of its anticholinergic side effects. The glycopyrrolate was then replaced with oral
clonidine 0.15 mg twice a day. Clonidine was well tolerated without remarkable side effects and he quickly started
to feel marked improvement which was maintained for 2 years.
Conclusions: I report an atypical presentation of primary hyperhidrosis and hot flushes that was effectively
controlled by clonidine without remarkable side effects. Further research on a large number of patients may be
required before recommending clonidine in similar conditions.
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Hyperhidrosis is a skin condition characterized by dys-
functional (excessive and unpredictable) sweating that
often causes significant impairment of emotional and
psychological well-being and may affect a person’s ability
to carry out daily and occupational activities [1]. The
prevalence of hyperhidrosis in the general population
was estimated at approximately 3 %, with much higher
prevalence among patients at a dermatology clinic [2, 3].
Primary (idiopathic) hyperhidrosis constitutes more than
90 % of the cases of hyperhidrosis and is diagnosed after
excluding relevant underlying diseases or drug intake
[4]. Common causes of secondary hyperhidrosis include
endocrinal diseases, neurologic diseases, infection,Correspondence: dr.aalbadrani@gmail.com
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hyperhidrosis is unknown, but is believed to be related
to overactivity of the sympathetic nervous system in
which acetylcholine is the neurotransmitter between a
nerve ending and a sweat gland [1]. Another symptom
that can be seen in relation with hyperhidrosis is hot
flushes. They are characterized by a feeling of intense
warmth, often accompanied by profuse sweating, anx-
iety, skin reddening, and palpitations, and sometimes
followed by chills [6]. Hot flushes are believed to be
caused by altered peripheral vascular reactivity and a
narrowed thermoregulatory zone [7]. Hot flushes are
well known in women: they affect approximately 75 % of
menopausal women, with more than half of them seek
medical advice [6]. However, the information about its
prevalence in men and underlying etiology is very lim-
ited [8]. Hot flushes are mainly related to a sharp decline
in the levels of testosterone as seen in patients withle is distributed under the terms of the Creative Commons Attribution 4.0
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[8]. However, rare medical conditions, some medica-
tions, and certain foods were associated with flushing of
mainly the face and neck [9]. Here I report the diagnosis
and the management of a rare case of hyperhidrosis and
hot flushes in a patient with hypothyroidism.Case presentation
A 29-year-old man of Arab origin presented to a derma-
tology clinic with a complaint of increased sweating, with
heavier involvement of his inguinal region, axilla, and
lower back. The complaint was associated with a transient
hot sensation and erythema over the affected area. Both
complaints appeared for the first time 3 years ago and had
progressed since then. His symptoms continued on a daily
basis without diurnal variation and were aggravated by hot
weather, caffeine, and anxiety. His sweating complaint was
so severe (score 4 based on Hyperhidrosis Disease Severity
Scale) that he had to change his clothes several times a
day. This negatively affected his social interaction, quality
of life, and the ability to work. He tried several over-the-
counter antiperspirants with no significant improvement.
He had no symptoms suggesting hyperthyroidism (includ-
ing tremors, palpitation, and frequent bowel movements),
tuberculosis/malignancy (fever, fatigue, loss of weight, and
cough), or eczema/allergy (including skin changes, prur-
itus, and wheezing). He was not a tobacco smoker or alco-
hol user. He was single with no sexual history. He was
socially and economically stable and living with family. He
had no previous surgeries with the exception of an
appendectomy when he was a teenager. He claimed that
he was not taking any medications. His family history
revealed no similar conditions and was negative for
tuberculosis.
On examination, he was conscious and oriented with
stable vital signs and without orthostatic changes. His chest
was clear with no signs of infection or wheezing. Heart and
blood vessels were normal with no signs of heart failure.
His abdomen was soft and lax with no tenderness, organo-
megaly, or masses. His central nervous system was grossly
intact. Joints were normal with no swelling or tenderness.
There was no lymphadenopathy, jaundice, or pallor. La-
boratory findings showed normal complete blood count,
sedimentation rate, electrolytes, blood glucose, liver func-
tion, and renal function. A lipid profile showed normal
low-density lipoprotein (LDL) and high-density lipoprotein
(HDL) cholesterol and triglycerides but slightly high total
cholesterol. A bone profile showed normal calcium, phos-
phate, alkaline phosphatase, and parathyroid hormone but
low vitamin D. His uric acid just crossed the upper limit.
Thyroid function tests showed normal levels of thyroxine
(FT4, 13.8 pmol/L) and thyroid-stimulating hormone
(TSH, 3.8 mU/L).He was treated by topical antiperspirants containing
aluminum chloride (Drysol) but without much improve-
ment. To respond to his request of symptomatic treat-
ment of the embarrassing inguinal hyperhidrosis, 50 U
Botox (botulinum toxin A) was injected into each in-
guinal area after localization of sweating activity using a
starch-iodine test. Injections were done using local
anesthetic, approximately 1 to 2 cm apart, and were well
tolerated with no complaint of pain or discomfort. He
experienced some improvement in the inguinal hyperhi-
drosis for the first 3 months after the injections, but
then the condition worsened.
He was then referred to an endocrinology clinic to rule
out secondary causes of hyperhidrosis and hot flushes. He
was reassessed and laboratory tests were repeated with no
remarkable changes compared with the initial assessment.
To evaluate endocrine causes of hyperhidrosis, a detailed
hormonal profile was examined and showed normal thy-
roid function (FT4 and TSH), adrenal function (cortisol
and dehydroepiandrosterone) and reproductive function
(follicle-stimulating hormone, luteinizing hormone, testos-
terone, progesterone, estradiol, and prolactin), and
insulin-like growth factor. In addition, to assess the pres-
ence of neuroendocrine tumors, a 24-hour urine collec-
tion was examined for 5-hydroxyindoleacetic acid and
vanillylmandelic acid and his blood was examined for
chromogranin. The results of the last three tests were high
(95.1 umol/day, 104.4 umol/day, and 8.0 nmol/L, respect-
ively), suggesting the presence of carcinoid or other neu-
roendocrine tumors. Therefore, a series of tests was done
to confirm the presence and locate the site of such
tumors. Computed tomography of his chest, abdomen,
and pelvis was normal. A lower gastrointestinal endoscopy
and bronchoscopy were normal. A whole body octreotide
scan (somatostatin receptor scintigraphy) showed small
focal increase of tracer uptake in his liver. However,
single-photon emission computed tomography (SPECT)
scan magnetic resonance imaging of his liver was unre-
markable. In addition, repeated blood chromogranin A
and 24-hour urine 5-hydroxyindoleacetic acid tests done 3
months later were normal (3.0 nmol/L and 26.2 umol/day,
respectively).
After ruling out secondary causes, he was diagnosed as
having primary generalized hyperhidrosis and hot
flushes. The endocrinologist started my patient on oral
glycopyrrolate (Robinul) 2 mg twice a day for 3 months.
However, his hyperhidrosis and hot flushes did not im-
prove and he was additionally complaining of anticholin-
ergic side effects of glycopyrrolate such as dry mouth
and constipation. The glycopyrrolate was then replaced
with oral clonidine 0.15 mg twice a day. Clonidine was
well tolerated without remarkable side effects. After he
was started on clonidine he had regular blood pressure
monitoring which showed no evidence of hypotension
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both his hyperhidrosis and hot flushes (score 1 based on
Hyperhidrosis Disease Severity Scale). According to the
last patient contact, the improvement was still main-
tained on clonidine 2 years later without remarkable side
effects.
Discussion
I report a case of primary generalized hyperhidrosis and
hot flushes that was effectively controlled by clonidine. The
occurrence of hyperhidrosis and hot flushes in a young
man is a rare presentation. Moreover, the atypical presenta-
tion of primary hyperhidrosis in the inguinal region is an-
other rare location of primary hyperhidrosis which usually
affects axillae, palms, soles, and craniofacial areas [4].
The primary hyperhidrosis diagnosis in my patient was
confirmed after an exhaustive search of underlying
causes such as diabetes, hyperthyroidism, pheochromo-
cytoma, carcinoid syndrome, malignancy, tuberculosis,
heart and lung diseases, alcohol intake, and relevant
medications [4, 5]. Similar to this case, the onset of pri-
mary hyperhidrosis was frequently reported at the age of
25 years or younger and the presentation is usually bilat-
eral, symmetric, and focal [4]. However, some character-
istics frequently linked to cases of primary hyperhidrosis
were lacking, such as positive family history and cessa-
tion of focal sweating during sleep [5]. Similarly, carcin-
oid or other neuroendocrine tumors, alcohol intake, and
relevant medications were excluded as possible causes of
hot flushes [9].
Clonidine in this report was more effective and toler-
able than glycopyrrolate in relieving the symptoms of
both hyperhidrosis and hot flushes. Clonidine is a cen-
trally acting alpha adrenergic receptor agonist that re-
duces sympathetic stimulation, whereas glycopyrrolate
inhibits synaptic acetylcholine and therefore interferes
with neuroglandular signaling [10]. Although clonidine
is not usually listed in the management of hyperhidrosis
[5, 11], both drugs were recently shown to be effective
as systemic treatment for primary hyperhidrosis [10].
However, oral medications for hyperhidrosis were only
recommended after failure of topical aluminum chloride
and botulinum toxin A for the fear of intolerability [11].
In addition, clonidine was shown to be an effective treat-
ment for hot flushes in menopausal women [6]. The re-
lief of both hyperhidrosis and hot flushes by clonidine
may reflect the role of sympathetic stimulation in both
condition and importance of central inhibition of sympa-
thetic stimulation in concomitant presentation and re-
fractory cases of hyperhidrosis.
Conclusions
I here report a case with atypical presentation of idiopathic
generalized hyperhidrosis and hot flushes that wereeffectively controlled by clonidine without remarkable side
effects. Further research on a large number of patients may
be required before recommending clonidine in similar
conditions.
Patient’s perspective
I was sweating constantly due to an unknown cause. I
always had red skin, was hot and sweating all over my
body especially my groin, armpits and lower back. I had
to keep my air conditioning on at home 24/7 just so I
wouldn't sweat. My doctor gave me clonidine 0.15 mg
twice daily after non-effective topical management and
almost immediately I noticed a difference. I have been
on it for almost 2 years now and my sweating completely
stopped and is under control. Thanks to clonidine the
sweating has stopped and I can wear now whatever I
want and be comfortable like a normal person without
being completely drenched in sweat!!
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